AHL-15877-01040
4 vaccinations
2 coded responses
49 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 530 / WI
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Pfizer-BioNTech
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-08
- 2021-05-13
- 2021-05-20
-
2021-05-27
Survey response — day 35, dose 2MedDRA: Cough, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: FairFree text: Post-nasal drip, congestion, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-03
- 2021-07-22
- 2021-10-21
-
2021-11-19
Dose 3 — Moderna
- 2021-11-19
- 2021-11-20
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-27
- 2021-12-05
- 2021-12-12
- 2021-12-19
- 2021-12-24
- 2022-01-02
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Endometrial cancer, Hysterectomy, Office visit, Surgery, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Endometrial cancer, and subsequent hysterectomy · Healthcare visit (other): Hysteroscopy, D&C, then oncologist visit, then surgeryMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prHospitalization · 1 call case(s)
- 2022-02-22
- 2022-05-22
-
2022-09-07
Dose 4 — ModernaCo-administered: Flu
- 2022-09-07
- 2022-09-08
- 2022-09-09
- 2022-09-10
- 2022-09-21
- 2022-10-05
- 2022-10-14
- 2022-10-21
- 2022-12-09
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-11-19 | Moderna | No |
| 4 | 2022-09-07 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-02-18 | Unsuccessful |
Free text
Release 8 — day 35, dose 2
Symptoms: Post-nasal drip, congestion, cough
Release 11 — 3 months, dose 3
Symptoms: Endometrial cancer, and subsequent hysterectomy
Healthcare visit (other): Hysteroscopy, D&C, then oncologist visit, then surgery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| HCVO | Surgery | · | · | ✓ |
| HCVO | Uterine dilation and curettage | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Endometrial cancer | · | · | ✓ |
| SD | Hysterectomy | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Upper-airway cough syndrome | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release